University Hospital of North Norway

unn.no

Total trials

148

Active

25

Phase 3

5

Total enrollment

43,672

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 10 of 10 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
PRP1
ADSTEM Inj.1
Injection1
Saline1
Fecal microbiota transplantation1
Ketamine Hydrochloride1
Midazolam Hydrochloride1
FMT1
Biological: Preprocessed thawed donor FMT1
Para Aminohippurate1

Next readouts

  • 2023-09-01
  • 2025-05
  • 2025-12
  • 2026-10
  • 2026-12-31
  • 2027-07-01

Top conditions

  • Stroke5
  • Stroke, Acute3
  • Quality of Life3
  • Breast Cancer3
  • Irritable Bowel Syndrome3
  • Alzheimer Disease2
  • Ischemic Stroke2
  • Heart Failure2

Frequently asked questions about University Hospital of North Norway

How many clinical trials does University Hospital of North Norway have on ClinicalTrials.gov?
University Hospital of North Norway is listed as the lead sponsor on 148 clinical trials in ClinicalTrials.gov, 25 of which are currently active (recruiting, enrolling, or ongoing).
How many of University Hospital of North Norway's trials are in Phase 3?
5 of University Hospital of North Norway's trials are in Phase 3, spread across 10 active drug programs.
What therapeutic areas does University Hospital of North Norway focus on?
University Hospital of North Norway's most-studied conditions on ClinicalTrials.gov are Stroke, Stroke, Acute, Quality of Life, Breast Cancer, Irritable Bowel Syndrome.
When are University Hospital of North Norway's next clinical trial readouts?
University Hospital of North Norway has 6 upcoming primary-completion readouts tracked here; the soonest is “Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome”, expected around 2023-09-01.